Toxicological assessment of Xanthigen® nutraceutical extract combination: Mutagenicity, genotoxicity and oral toxicity.
Toxicol Rep
; 5: 1021-1031, 2018.
Article
em En
| MEDLINE
| ID: mdl-30386730
BSE, brown seaweed extract; CPA, cytophosphadine; DMSO, dimethyl sulfoxide; FX, fucoxanthin; Functional foods; Genotoxicity; KFDA, Korean Food and Drug Administration; LD50, oral lethal dose 50%; MMC, mitomycin; MNPCEs, micronucleated polychromatic erythrocytes; MUFA, monounsaturated fatty acids; NCE, normochromatic erythrocytes; NOAEL, no observed adverse effect level; Nutraceutical; Oral toxicity; PCE, polychromatic erythrocytes; PSO, pomegranate seed oil; PUFA, polyunsaturated fatty acid; RCC, relative cell count; S9, metabolic activation system consisting of liver-derived cell extract; SFA, saturated fatty acids; SPF, specific pathogenic free; Xanthigen
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article